US2011166216A1PendingUtilityA1

Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma

47
Assignee: BURNHAM INST MEDICAL RESEARCHPriority: Aug 17, 2007Filed: Feb 4, 2011Published: Jul 7, 2011
Est. expiryAug 17, 2027(~1.1 yrs left)· nominal 20-yr term from priority
A61P 35/00C07C 235/82C07C 2603/52C07J 63/008A61P 35/04
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There are provided methods of inhibiting growth and metastasis of melanoma, methods of sensitizing melanoma cells to apoptosis, and methods of treating a subject having melanoma using acetyl isogambogic acid, celastrol, or a derivative thereof. There are further provided derivatives of celastrol and compositions comprising acetyl isogambogic acid, celastrol, or a derivative thereof.

Claims

exact text as granted — not AI-modified
1 . A method for inhibiting melanoma growth comprising contacting the melanoma with an effective amount of acetyl isogambogic acid. 
     
     
         2 . A method of sensitizing melanoma cells to apoptosis comprising contacting the cells with an effective amount of acetyl isogambogic acid. 
     
     
         3 . A method of treating melanoma in a subject in need thereof comprising administering an effective amount of acetyl isogambogic acid. 
     
     
         4 . The method of  claim 3 , wherein the administering is via topical administration or subcutaneous administration. 
     
     
         5 . The method of  claim 3 , wherein the acetyl isogambogic acid is formulated in a pharmaceutical composition.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.